Nije utvr?ena bezbednost i efikasnost primene filgrastima kod pacijenata sa mijelodisplasti?nim sindromom ili hroni?nom mijeloidnom leukemijom.NIVESTYM is indicated for your mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis [see Clinical Research].Patient self-administration and admi